Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma

Journal of Hepatology

Volumn 49, Issue 5, 2008, Pages 746-757

  Tanaka, Yasuo ^a   Kanai, Fumihiko ^a   Tada, Motohisa ^a,b   Tateishi, Ryosuke ^a   Sanada, Masashi ^a   Nannya, Yasuhito ^a   Ohta, Miki ^a   Asaoka, Yoshinari ^a   Seto, Motoko ^a   Shiina, Shuichiro ^a   Yoshida, Haruhiko ^a   Kawabe, Takao ^a   Yokosuka, Osamu ^b   Ogawa, Seishi ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Copy number alteration; Genetic marker; High density single nucleotide polymorphism array; Loss of heterozygosity; Recurrence

Indexed keywords

GENOMIC DNA; HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CELL PROLIFERATION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GRHL2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHILD; DISEASE-FREE SURVIVAL; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; GENE DOSAGE; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECURRENCE; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 53449092318     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.06.019     Document Type: Article

References (47)

1. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
2. Ikai I., Arii S., Okazaki M., Okita K., Omata M., Kojiro M., et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 37 (2007) 676-691
3. Shiina S., Teratani T., Obi S., Sato S., Tateishi R., Fujishima T., et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129 (2005) 122-130
4. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998;28:751-755.
5. Llovet J.M., Bru C., and Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
6. Kudo M., Chung H., and Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan integrated staging score (JIS score). J Gastroenterol 38 (2003) 207-215
7. Tateishi R., Yoshida H., Shiina S., Imamura H., Hasegawa K., Teratani T., et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 54 (2005) 419-425
8. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339-346
9. Villanueva A., Newell P., Chiang D.Y., Friedman S.L., and Llovet J.M. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27 (2007) 55-76
10. Kusano N., Okita K., Shirahashi H., Harada T., Shiraishi K., Oga A., et al. Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma. Cancer 94 (2002) 746-751
11. Katoh H., Shibata T., Kokubu A., Ojima H., Loukopoulos P., Kanai Y., et al. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. J Hepatol 43 (2005) 863-874
12. Tornillo L., Carafa V., Richter J., Sauter G., Moch H., Minola E., et al. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas. J Pathol 192 (2000) 307-312
13. Patil M.A., Gutgemann I., Zhang J., Ho C., Cheung S.T., Ginzinger D., et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 26 (2005) 2050-2057
14. Huang J., Sheng H.H., Shen T., Hu Y.J., Xiao H.S., Zhang Q., et al. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma. FEBS Lett 580 (2006) 3571-3581
15. Zhao X., Li C., Paez J.G., Chin K., Janne P.A., Chen T.H., et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64 (2004) 3060-3071
16. Nannya Y., Sanada M., Nakazaki K., Hosoya N., Wang L., Hangaishi A., et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 65 (2005) 6071-6079
17. Midorikawa Y., Yamamoto S., Ishikawa S., Kamimura N., Igarashi H., Sugimura H., et al. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene 25 (2006) 5581-5590
18. Moskaluk C.A., and Kern S.E. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 150 (1997) 1547-1552
19. Yamamoto G., Nannya Y., Kato M., Sanada M., Levine R.L., Kawamata N., et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am J Hum Genet 81 (2007) 114-126
20. Ohta M., Tateishi K., Kanai F., Watabe H., Kondo S., Guleng B., et al. p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. Cancer Res 65 (2005) 10822-10829
21. Smyth I., Narang M.A., Evans T., Heimann C., Nakamura Y., Chenevix-Trench G., et al. Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. Hum Mol Genet 8 (1999) 291-297
22. Zhang Y.J., Jiang W., Chen C.J., Lee C.S., Kahn S.M., Santella R.M., et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196 (1993) 1010-1016
23. Nishida N., Fukuda Y., Komeda T., Kita R., Sando T., Furukawa M., et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54 (1994) 3107-3110
24. Heidenblad M., Jonson T., Mahlamaki E.H., Gorunova L., Karhu R., Johansson B., et al. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification. Genes Chromosomes Cancer 34 (2002) 211-223
25. Trauzold A., Schmiedel S., Sipos B., Wermann H., Westphal S., Roder C., et al. PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene 22 (2003) 8939-8947
26. van Dartel M., Cornelissen P.W., Redeker S., Tarkkanen M., Knuutila S., Hogendoorn P.C., et al. Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma. Cancer Genet Cytogenet 139 (2002) 91-96
27. Allikmets R. Simple and complex ABCR: genetic predisposition to retinal disease. Am J Hum Genet 67 (2000) 793-799
28. De Valck D., Jin D.Y., Heyninck K., Van de Craen M., Contreras R., Fiers W., et al. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene 18 (1999) 4182-4190
29. Peters L.M., Anderson D.W., Griffith A.J., Grundfast K.M., San Agustin T.B., Madeo A.C., et al. Mutation of a transcription factor, TFCP2L3, causes progressive autosomal dominant hearing loss, DFNA28. Hum Mol Genet 11 (2002) 2877-2885
30. Dowler S., Currie R.A., Campbell D.G., Deak M., Kular G., Downes C.P., et al. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J 351 (2000) 19-31
31. Walker D.M., Urbe S., Dove S.K., Tenza D., Raposo G., and Clague M.J. Characterization of MTMR3. An inositol lipid 3-phosphatase with novel substrate specificity. Curr Biol 11 (2001) 1600-1605
32. Yasui K., Arii S., Zhao C., Imoto I., Ueda M., Nagai H., et al. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 35 (2002) 1476-1484
33. Zimonjic D.B., Keck C.L., Thorgeirsson S.S., and Popescu N.C. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 29 (1999) 1208-1214
34. Yuan B.Z., Miller M.J., Keck C.L., Zimonjic D.B., Thorgeirsson S.S., and Popescu N.C. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 58 (1998) 2196-2199
35. Piao Z., Kim H., Jeon B.K., Lee W.J., and Park C. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma. Cancer 80 (1997) 865-872
36. Jin M., Piao Z., Kim N.G., Park C., Shin E.C., Park J.H., et al. p16 is a major inactivation target in hepatocellular carcinoma. Cancer 89 (2000) 60-68
37. Hsu H.C., Peng S.Y., Lai P.L., Sheu J.C., Chen D.S., Lin L.I., et al. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer 73 (1994) 42-47
38. Melchiorri C., Bolondi L., Chieco P., Pagnoni M., Gramantieri L., and Barbara L. Diagnostic and prognostic value of DNA ploidy and cell nuclearity in ultrasound-guided liver biopsies. Cancer 74 (1994) 1713-1719
39. Cottier M., Jouffre C., Maubon I., Sabido O., Barthelemy C., Cuilleron M., et al. Prospective flow cytometric DNA analysis of hepatocellular carcinoma specimens collected by ultrasound-guided fine needle aspiration. Cancer 74 (1994) 599-605
40. Mise K., Tashiro S., Yogita S., Wada D., Harada M., Fukuda Y., et al. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinico-pathological factors and prognosis. Clin Cancer Res 4 (1998) 1475-1482
41. Marchio A., Meddeb M., Pineau P., Danglot G., Tiollais P., Bernheim A., et al. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 18 (1997) 59-65
42. Wong N., Lai P., Lee S.W., Fan S., Pang E., Liew C.T., et al. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 154 (1999) 37-43
43. Kusano N., Shiraishi K., Kubo K., Oga A., Okita K., and Sasaki K. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinico-pathological features. Hepatology 29 (1999) 1858-1862
44. Guan X.Y., Fang Y., Sham J.S., Kwong D.L., Zhang Y., Liang Q., et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 29 (2000) 110-116
45. Poon R.T., Fan S.T., Ng I.O., Lo C.M., Liu C.L., and Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89 (2000) 500-507
46. Kumada T., Nakano S., Takeda I., Sugiyama K., Osada T., Kiriyama S., et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25 (1997) 87-92
47. Sakon M., Umeshita K., Nagano H., Eguchi H., Kishimoto S., Miyamoto A., et al. Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. Arch Surg 135 (2000) 1456-1459